SEC Form 4 · accession 0000899243-15-004425

PROTHENA CORP PUBLIC LTD CO · PRTA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 1, 2015

Accepted (ET)

Sep 3, 2015 · 4:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001559053

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Ordinary Shares, par value $0.01 per share	Sep 1, 2015	M	3,125	$16.42	A	5,970	D
Ordinary Shares, par value $0.01 per share^F2	Sep 1, 2015	S	1,100	$54.8823	D	4,870	D
Ordinary Shares, par value $0.01 per share^F3	Sep 1, 2015	S	2,025	$55.7578	D	2,845	D
Ordinary Shares, par value $0.01 per share	holding	—	—		—	1,363	I	By wife

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)	$16.42	Sep 1, 2015	M	3,125	D	Jul 22, 2014	Jul 21, 2023	Ordinary Shares	3,125	40,625	D

F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
F2The transaction was executed in multiple trades in prices ranging from $54.355 to $55.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
F3The transaction was executed in multiple trades in prices ranging from $55.41 to $56.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.